Biologics and Biosimilars
A section of Pharmaceutics (ISSN 1999-4923).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Peptides-Based Antiviral Agents (Deadline: 30 April 2024)
- Polypeptides and Bioconjugates: Synthesis, Anticancer and/or Antimicrobial Activities (Deadline: 30 April 2024)
- Extracellular Vesicles for Early Cancer Diagnosis and Therapy (Deadline: 30 April 2024)
- Exosomes as Drug Carriers for Cancer Therapy (Deadline: 10 May 2024)
- Extracellular Vesicles as Drug Delivery Vehicles for Cancer Therapy (Deadline: 31 May 2024)
- Advances in Pharmacogenomic Studies (Deadline: 31 May 2024)
- Delivery Systems on the Antioxidant Activity of Natural Bioactive Compounds (Deadline: 31 May 2024)
- Protein Kinase Inhibitors for Targeted Anticancer Therapies, 2nd Edition (Deadline: 30 June 2024)
- Advances in Delivering Protein and Peptide Therapeutics, 2nd Edition (Deadline: 30 June 2024)
- The 15th Anniversary of Pharmaceutics—Aptamers as Novel Therapeutics (Deadline: 31 August 2024)
- Hyaluronic Acid for Medical Applications (Deadline: 30 September 2024)
- Biomedical Applications of Bioactive Cell Penetrating Peptides and Development of Novel Biologics (Deadline: 30 September 2024)
- Steroid Derivatives: Design and Pharmaceutical Application (Deadline: 1 October 2024)
- Biotechnology Applications and Innovative Approaches for Cancer Prevention and Treatment (BIO-APP) (Deadline: 20 October 2024)